France· FR:66827036
LANVIS 40 mg, comprimé sécable
A medicinal product containing thioguanine, registered in France by ASPEN PHARMA TRADING (IRLANDE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- THIOGUANINE
- Manufacturer
- ASPEN PHARMA TRADING (IRLANDE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip133400936923003flacon(s) en verre brun de 25 comprimé(s) avec fermeture de sécurité enfant
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Thioguanine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomLanvis 40mg tabletsAspen Pharma Trading Ltd
- NorwayLanvisGlaxoSmithKline
- SpainLANVIS 40 MG COMPRIMIDOSAspen Pharma Trading Limited
- SwedenLanvis 40 mg TablettAspen Pharma Trading Limited
- NetherlandsLanvis 40 mg tablettenAspen Pharma Trading Limited
- PolandLanvisAspen Pharma Trading Ltd.
- CanadaLANVISASPEN PHARMACARE CANADA INC.
- United StatesTABLOIDWaylis Therapeutics LLC
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Thioguanin Aspen
- Belgium · Lanvis
- Czechia · Lanvis
- Germany · Thioguanin Aspen
- Estonia · Lanvis
- Spain · Lanvis
- Ireland · Lanvis
- Italy · Tioguanina
- Lithuania · Lanvis
- Netherlands · Lanvis, Thiosix
- Poland · Lanvis
- Romania · Lanvis
- Sweden · Lanvis
- Slovakia · Lanvis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d60c6827-fb45-415e-aa0f-5aead2de16d6 GET /v1/drugs/d60c6827-fb45-415e-aa0f-5aead2de16d6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66827036",
"date_amm": "1999-07-08",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "THIOGUANINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé sécable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about thioguanine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.